Literature DB >> 28405607

Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa.

Maud Deruaz1, Thomas T Murooka1, Sophina Ji1, Marc A Gavin2, Vladimir D Vrbanac1, Judy Lieberman3, Andrew M Tager1, Thorsten R Mempel1, Andrew D Luster1.   

Abstract

HIV vaginal transmission accounts for the majority of newly acquired heterosexual infections. However, the mechanism by which HIV spreads from the initial site of viral entry at the mucosal surface of the female genital tract to establish a systemic infection of lymphoid and peripheral tissues is not known. Once the virus exits the mucosa it rapidly spreads to all tissues, leading to CD4+ T cell depletion and the establishment of a viral reservoir that cannot be eliminated with current treatments. Understanding the molecular and cellular requirements for viral dissemination from the genital tract is therefore of great importance, as it could reveal new strategies to lengthen the window of opportunity to target the virus at its entry site in the mucosa where it is the most vulnerable and thus prevent systemic infection. Using HIV vaginal infection of humanized mice as a model of heterosexual transmission, we demonstrate that blocking the ability of leukocytes to respond to chemoattractants prevented HIV from leaving the female genital tract. Furthermore, blocking lymphocyte egress from lymph nodes prevented viremia and infection of the gut. Leukocyte trafficking therefore plays a major role in viral dissemination, and targeting the chemoattractant molecules involved can prevent the establishment of a systemic infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28405607      PMCID: PMC5374062          DOI: 10.1172/jci.insight.88533

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  50 in total

Review 1.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

Authors:  Jason G Cyster; Susan R Schwab
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

2.  The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.

Authors:  Levi G Ledgerwood; Girdhari Lal; Nan Zhang; Alexandre Garin; Steven J Esses; Florent Ginhoux; Miriam Merad; Helene Peche; Sergio A Lira; Yaozhong Ding; Yu Yang; Xingxuan He; Edward H Schuchman; Maria L Allende; Jordi C Ochando; Jonathan S Bromberg
Journal:  Nat Immunol       Date:  2007-11-25       Impact factor: 25.606

3.  Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.

Authors:  Lee Adam Wheeler; Radiana Trifonova; Vladimir Vrbanac; Emre Basar; Shannon McKernan; Zhan Xu; Edward Seung; Maud Deruaz; Tim Dudek; Jon Ivar Einarsson; Linda Yang; Todd M Allen; Andrew D Luster; Andrew M Tager; Derek M Dykxhoorn; Judy Lieberman
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

4.  Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin.

Authors:  G J Spangrude; F Sacchi; H R Hill; D E Van Epps; R A Daynes
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

5.  Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.

Authors:  Jeffrey Pudney; Alison J Quayle; Deborah J Anderson
Journal:  Biol Reprod       Date:  2005-08-10       Impact factor: 4.285

6.  S1P-Dependent trafficking of intracellular yersinia pestis through lymph nodes establishes Buboes and systemic infection.

Authors:  Ashley L St John; W X Gladys Ang; Min-Nung Huang; Christian A Kunder; Elizabeth W Chan; Michael D Gunn; Soman N Abraham
Journal:  Immunity       Date:  2014-09-18       Impact factor: 31.745

7.  HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5.

Authors:  M Farzan; H Choe; K A Martin; Y Sun; M Sidelko; C R Mackay; N P Gerard; J Sodroski; C Gerard
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

Review 8.  In vivo platforms for analysis of HIV persistence and eradication.

Authors:  J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-01       Impact factor: 14.808

9.  HIV-infected T cells are migratory vehicles for viral dissemination.

Authors:  Thomas T Murooka; Maud Deruaz; Francesco Marangoni; Vladimir D Vrbanac; Edward Seung; Ulrich H von Andrian; Andrew M Tager; Andrew D Luster; Thorsten R Mempel
Journal:  Nature       Date:  2012-08-01       Impact factor: 49.962

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  8 in total

1.  Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.

Authors:  Catia T Perciani; Bashir Farah; Rupert Kaul; Mario A Ostrowski; Salaheddin M Mahmud; Omu Anzala; Walter Jaoko; Kelly S MacDonald
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

Review 2.  In Vivo Imaging-Driven Approaches to Study Virus Dissemination and Pathogenesis.

Authors:  Pradeep D Uchil; Kelsey A Haugh; Ruoxi Pi; Walther Mothes
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

3.  Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis.

Authors:  Zengzi Zhou; Lingxiang Xie; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

4.  Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.

Authors:  Vineet Joag; Onyango Obila; Pawel Gajer; Milcah Carol Scott; Sara Dizzell; Michael Humphrys; Kamnoosh Shahabi; Sanja Huibner; Brett Shannon; Wangari Tharao; Marianne Mureithi; Julius Oyugi; Joshua Kimani; Charu Kaushic; Jacques Ravel; Omu Anzala; Rupert Kaul
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

5.  Frequency of Human CD45+ Target Cells is a Key Determinant of Intravaginal HIV-1 Infection in Humanized Mice.

Authors:  Philip V Nguyen; Jocelyn M Wessels; Kristen Mueller; Fatemeh Vahedi; Varun Anipindi; Chris P Verschoor; Marianne Chew; Alexandre Deshiere; Uladzimir Karniychuk; Tony Mazzulli; Michel J Tremblay; Ali A Ashkar; Charu Kaushic
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

6.  HIV-1 and SIV Infection Are Associated with Early Loss of Lung Interstitial CD4+ T Cells and Dissemination of Pulmonary Tuberculosis.

Authors:  Björn Corleis; Allison N Bucsan; Maud Deruaz; Vladimir D Vrbanac; Antonella C Lisanti-Park; Samantha J Gates; Alice H Linder; Jeffrey M Paer; Gregory S Olson; Brittany A Bowman; Abigail E Schiff; Benjamin D Medoff; Andrew M Tager; Andrew D Luster; Shabaana A Khader; Deepak Kaushal; Douglas S Kwon
Journal:  Cell Rep       Date:  2019-02-05       Impact factor: 9.423

7.  B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection.

Authors:  Martin Trapecar; Shahzada Khan; Benjamin L Cohn; Frank Wu; Shomyseh Sanjabi
Journal:  Mucosal Immunol       Date:  2018-02-19       Impact factor: 7.313

Review 8.  Impact of Endemic Infections on HIV Susceptibility in Sub-Saharan Africa.

Authors:  Sergey Yegorov; Vineet Joag; Ronald M Galiwango; Sara V Good; Brenda Okech; Rupert Kaul
Journal:  Trop Dis Travel Med Vaccines       Date:  2019-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.